TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy

doi 10.5772/intechopen.85632
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IntechOpen

Related search

Regulatory T Cells in Cancer Immunotherapy

Current Opinion in Immunology
AllergyImmunology
2014English

Regulatory T Cells in Cancer Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Regulatory T Cells in Cancer

Annual Review of Cancer Biology
2020English

Epitherapy and Immune Checkpoint Blockade: Using Epigenetic Reinvigoration of Exhausted and Dysfunctional T Cells to Reimburse Immunotherapy Response

BMC Immunology
Immunology
2020English

A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2

Clinical Cancer Research
Cancer ResearchOncology
2015English

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Regulatory T Cells and Immune Tolerance in the Intestine

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2013English

Anti-Regulatory T Cell Vaccines in Immunotherapy: Focusing on FoxP3 as Target

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation

Frontiers in Immunology
AllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy